Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

The Latest Pharma Jobs, News and Events

pharmiweb.com today | 30 September 2014

Kymab strengthens and expands capabilities

Kymab, a monoclonal antibody biopharmaceutical company founded on research from the Wellcome Trust Sanger Institute, announced today the appointment of Dr Timothy Wells and Lisha Patel to its Board as Non-Executive Directors and Jenny Yip as a Board Observer, effective from 23 September 2014. Dr Richard Davis will stand down as Non-Executive Director.

 

Dr Timothy Wells, a protein engineer by training, is currently Chief Scientific Officer of the Medicines for Malaria Venture (MMV) in Geneva and was previously Senior Executive Vice President Research at Serono. Lisha Patel is Head of Direct Private Investments at the Wellcome Trust and Jenny Yip is Senior Program Investment Officer on the Program Related Investments (PRI) team at the Bill & Melinda Gates Foundation (BMGF)....

 

Dr Christian Grøndahl, Chief Executive Officer of Kymab, commented:  “Following the successful US$40 million fundraising in May, we are delighted to strengthen our team and welcome Tim, Lisha and Jenny to the Kymab Board. Tim’s long and successful track record in developing valuable medicines within Serono and Medicines for Malaria Venture will strengthen our capabilities as we build Kymab into a global biotechnology company based on our world-class Kymouse technology. Additionally, Jenny and Lisha’s appointments reflect the high strategic importance Kymab has for both the Wellcome Trust and the Bill & Melinda Gates Foundation and for the long-term shared vision for building a sustainable successful company. I would also like to take this opportunity to thank Dr Richard Davis, acting on behalf of the Wellcome Trust, for his important contribution in building Kymab to the successful Company it is today.” 

show more

Latest Poll

Would you ever take part in a Clinical Trial?

Yes 44% 44%
Possibly 23% 23%
Probably not 20% 20%
Never 12% 12%
Advertising

Content

PharmiWeb.com is a product of PharmiWeb Solutions - a global provider of digital solutions for the pharmaceutical sector.

We increase engagement with healthcare professionals, patients, carers and consumers, through:

Click here to go to learn more about us.

Pharmiweb Solutions